| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 17.2 | 10.8 | 7.5 |
| Other income | 0.2 | 0.1 | 0.2 |
| Total income | 17.4 | 11.0 | 7.6 |
| Profit before exceptional items & tax | 2.3 | 0.9 | 0.2 |
| Profit before tax | 2.3 | 0.9 | 0.2 |
| Net profit | 1.7 | 0.5 | 0.2 |
| Operating margin | 13.2% | 8.2% | 2.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +750.00% |
|---|---|
| Net profit, quarter on quarter | +240.00% |
| Revenue, year on year | +129.30% |
| Operating profit, quarter on quarter | +162.50% |
Source
Read the filing ↗
NSE results filing, NSE: ARVEE. Figures extracted from the filing.
Arvee Laboratories (India) Ltd: key numbers
- Share price
- ₹213.19
- Market cap
- ₹234.9 Cr
- Revenue (annual)
- ₹31.51 Cr
- Net profit (annual)
- ₹2.53 Cr
- P/E (TTM)
- 58.0×Sector 37.5×
- Promoter holding
- 73.50%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Arvee Laboratories (India) Ltd
All →
18:00 IST
NSE
Management Change
Arvee Laboratories (India) Management Change
Arvee Laboratories announced the resignation of Raina Singh as Company Secretary and Compliance Officer, effective September 9, 2026.